\-\ Texto\\:\\ \ \(0\)\
\-\ unremarkable\\ physical\\ exam\\.\\ \\ normal\\ thyroid\\ function\\ panel\\.\ \(0\)\
\-\ this\\ patient\\ had\\ hyperthyroidism\\ that\\ was\\ previously\\ treated\\.\\ \\ currently\\,\\ her\\ thyroid\\ function\\ panel\\ within\\ normal\\ limits\\.\ \(0\)\
\-\ no\\ specific\\ treatment\\ for\\ the\\ osseous\\ findings\\ is\\ indicated\\.\ \(0\)\
\-\ multiple\\ areas\\ of\\ fluffy\\ diaphyseal\\ periosteal\\ reaction\\ \\-\\ involving\\ the\\ metacarpals\\ and\\ distal\\ radius\\ bilaterally\\.\\ \\ there\\ is\\ clubbing\\ of\\ the\\ distal\\ phalanges\\.\ \(0\)\
\-\ thyroid\\ acropachy\ \(3\)\
\-\ \\â\\€\\¢\\ ddx\\ for\\ periosteal\\ reaction\\ involving\\ multiple\\ bones\\:\ \(0\)\
\-\ \\Â\\»\\ hypertrophic\\ pulmonary\\ osteoarthropathy\ \(0\)\
\-\ \\Â\\»\\ venous\\ stasis\\,\\ vascular\\ insufficiency\ \(0\)\
\-\ \\Â\\»\\ hypervitaminosis\\ a\ \(0\)\
\-\ \\Â\\»\\ fluorosis\ \(0\)\
\-\ \\Â\\»\\ leukemia\ \(0\)\
\-\ \\Â\\»\\ infection\ \(0\)\
\-\ 44\\ y\\/o\\ woman\\,\\ with\\ history\\ of\\ treated\\ endocrine\\ abnormality\\.\ \(1\)\
\-\ the\\ imaging\\ findings\\ for\\ thyroid\\ acropachy\\ are\\ secondary\\ to\\ increased\\ bone\\ turnover\\ and\\ bone\\ loss\\ related\\ to\\ hyperthryoidism\\.\\ \\ 60\\-80\\%\\ of\\ cases\\ are\\ seen\\ secondary\\ to\\ grave\\â\\€\\™s\\ disease\\.\\ \\ osseous\\ findings\\ are\\ generally\\ seen\\ following\\ treatment\\ for\\ hyperthyroidism\\ \\(radioactive\\ iodine\\ or\\ thryoidectomy\\,\\)\\ as\\ in\\ this\\ case\\.\\ \\ associated\\ lab\\ abnormalities\\ include\\ elevated\\ serum\\ calcium\\,\\ phosphate\\,\\ alkaline\\ phosphatase\\,\\ and\\ hypercalciuria\\.\\ \\ there\\ is\\ no\\ correlation\\ between\\ the\\ thyroid\\ acropachy\\ and\\ current\\ thyroid\\ state\\.\ \(0\)\
\-\ clinical\\ signs\\ associated\\ with\\ hyperthyroidism\\ include\\ exophthalmos\\,\\ soft\\ tissue\\ swelling\\,\\ pretibial\\ myxedema\\,\\ clubbing\\,\\ and\\ periostitis\\.\ \(0\)\
\-\ characteristic\\ imaging\\ findings\\ include\\ a\\ fluffy\\ diaphyseal\\ reaction\\ which\\ is\\ most\\ pronounced\\ in\\ the\\ metacarpals\\,\\ commonly\\ involving\\ the\\ radial\\ aspects\\.\\ \\ soft\\ tissue\\ swelling\\ and\\ clubbing\\ can\\ also\\ be\\ identified\\ on\\ plain\\ film\\.\\ \\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ scanlon\\ gt\\,\\ clemett\\ ar\\.\\ \\ thryoid\\ acropachy\\.\\ radiology\\.\\ 1964\\.\\ dec\\;83\\:1039\\-42\\.\ \(0\)\
\-\ verney\\ gi\\.\\ thyroid\\ acropachy\\.\\ br\\ j\\ radiol\\.\\ 1962\\.\\ sep\\;35\\:644\\-6\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ acropachy\\:\\ 0\\.14985924803333123\ \(0\)\
\-\ \\Â\\»\\:\\ 0\\.0932180421692636\ \(0\)\
\-\ thyroid\\:\\ 0\\.09046563510875637\ \(0\)\
\-\ hyperthyroidism\\:\\ 0\\.061103485881500025\ \(0\)\
\-\ clubbing\\:\\ 0\\.058551563461442836\ \(0\)\
\-\ fluffy\\:\\ 0\\.053181405989168984\ \(0\)\
\-\ metacarpals\\:\\ 0\\.04612966100741669\ \(0\)\
\-\ diaphyseal\\:\\ 0\\.04558273870369918\ \(0\)\
\-\ reaction\\:\\ 0\\.042963592149473866\ \(0\)\
\-\ panel\\:\\ 0\\.03713157778633385\ \(0\)\
\-\ involving\\:\\ 0\\.033192700339519855\ \(0\)\
\-\ hyperthryoidism\\:\\ 0\\.03252958828031918\ \(0\)\
\-\ thryoidectomy\\:\\ 0\\.03252958828031918\ \(0\)\
\-\ scanlon\\:\\ 0\\.03252958828031918\ \(0\)\
\-\ gt\\:\\ 0\\.03252958828031918\ \(0\)\
\-\ clemett\\:\\ 0\\.03252958828031918\ \(0\)\
\-\ 83\\:1039\\-42\\.\\:\\ 0\\.03252958828031918\ \(0\)\
\-\ verney\\:\\ 0\\.03252958828031918\ \(0\)\
\-\ 1962\\.\\:\\ 0\\.03252958828031918\ \(0\)\
\-\ 35\\:644\\-6\\:\\ 0\\.03252958828031918\ \(0\)\
\-\ fluorosis\\:\\ 0\\.029971849606666247\ \(0\)\
\-\ ar\\:\\ 0\\.029971849606666247\ \(0\)\
\-\ 1964\\.\\:\\ 0\\.029971849606666247\ \(0\)\
\-\ periosteal\\:\\ 0\\.029913981469880013\ \(0\)\
\-\ myxedema\\:\\ 0\\.028475668395935013\ \(0\)\
\-\ thryoid\\:\\ 0\\.028475668395935013\ \(0\)\
\-\ hypercalciuria\\:\\ 0\\.02741411093301331\ \(0\)\
\-\ findings\\:\\ 0\\.026846301635276158\ \(0\)\
\-\ osseous\\:\\ 0\\.02677588648063279\ \(0\)\
\-\ function\\:\\ 0\\.026734771757020576\ \(0\)\
\-\ include\\:\\ 0\\.026536754480040073\ \(0\)\
\-\ hypervitaminosis\\:\\ 0\\.025917929722282077\ \(0\)\
\-\ 60\\-80\\:\\ 0\\.025917929722282077\ \(0\)\
\-\ pretibial\\:\\ 0\\.025917929722282077\ \(0\)\
\-\ turnover\\:\\ 0\\.024856372259360375\ \(0\)\
\-\ phosphate\\:\\ 0\\.023681266240472794\ \(0\)\
\-\ grave\\:\\ 0\\.02336019104862914\ \(0\)\
\-\ osteoarthropathy\\:\\ 0\\.023064830503708344\ \(0\)\
\-\ exophthalmos\\:\\ 0\\.023064830503708344\ \(0\)\
\-\ sep\\:\\ 0\\.02279136935184959\ \(0\)\
\-\ br\\:\\ 0\\.022536783110200322\ \(0\)\
\-\ periostitis\\:\\ 0\\.022298633585707443\ \(0\)\
\-\ radiol\\:\\ 0\\.022298633585707443\ \(0\)\
\-\ radioactive\\:\\ 0\\.02207492649413388\ \(0\)\
\-\ stasis\\:\\ 0\\.021295188141118356\ \(0\)\
\-\ swelling\\:\\ 0\\.021009674272923485\ \(0\)\
\-\ phalanges\\:\\ 0\\.020802452374976205\ \(0\)\
\-\ dec\\:\\ 0\\.020802452374976205\ \(0\)\
\-\ phosphatase\\:\\ 0\\.020651817708849805\ \(0\)\
\-\ alkaline\\:\\ 0\\.02010414241321042\ \(0\)\
\-\ pronounced\\:\\ 0\\.01997904443654739\ \(0\)\
\-\ iodine\\:\\ 0\\.01985804878037399\ \(0\)\
\-\ endocrine\\:\\ 0\\.019517187820480945\ \(0\)\
\-\ treated\\:\\ 0\\.018877127941578295\ \(0\)\
\-\ hypertrophic\\:\\ 0\\.018322401558141844\ \(0\)\
\-\ aspects\\:\\ 0\\.018168627770685872\ \(0\)\
\-\ state\\:\\ 0\\.01781008995351374\ \(0\)\
\-\ secondary\\:\\ 0\\.01763121746500965\ \(0\)\
\-\ radius\\:\\ 0\\.017360312028757145\ \(0\)\
\-\ correlation\\:\\ 0\\.017360312028757145\ \(0\)\
\-\ distal\\:\\ 0\\.017145967446096137\ \(0\)\
\-\ insufficiency\\:\\ 0\\.01674853249059204\ \(0\)\
\-\ ddx\\:\\ 0\\.016647429264805638\ \(0\)\
\-\ leukemia\\:\\ 0\\.016179710793812488\ \(0\)\
\-\ 44\\:\\ 0\\.016179710793812488\ \(0\)\
\-\ bone\\:\\ 0\\.015671104660220442\ \(0\)\
\-\ lab\\:\\ 0\\.015427267290541927\ \(0\)\
\-\ calcium\\:\\ 0\\.015427267290541927\ \(0\)\
\-\ soft\\:\\ 0\\.01535739309220332\ \(0\)\
\-\ serum\\:\\ 0\\.015218341482425663\ \(0\)\
\-\ tissue\\:\\ 0\\.014947757848358624\ \(0\)\
\-\ \\;\\:\\ 0\\.014947757848358624\ \(0\)\
\-\ associated\\:\\ 0\\.014881642523304072\ \(0\)\
\-\ imaging\\:\\ 0\\.014775452579008138\ \(0\)\
\-\ current\\:\\ 0\\.014772450437616533\ \(0\)\
\-\ radial\\:\\ 0\\.014456378686404378\ \(0\)\
\-\ j\\:\\ 0\\.014242403565923385\ \(0\)\
\-\ generally\\:\\ 0\\.014190793816939105\ \(0\)\
\-\ gi\\:\\ 0\\.014165257127475732\ \(0\)\
\-\ indicated\\:\\ 0\\.013644002256641119\ \(0\)\
\-\ characteristic\\:\\ 0\\.013346942408489567\ \(0\)\
\-\ radiology\\:\\ 0\\.013326611575238755\ \(0\)\
\-\ bones\\:\\ 0\\.013306392144372979\ \(0\)\
\-\ multiple\\:\\ 0\\.013282701132688332\ \(0\)\
\-\ previously\\:\\ 0\\.013246390222336889\ \(0\)\
\-\ references\\:\\ 0\\.01311006728805023\ \(0\)\
\-\ specific\\:\\ 0\\.013034371569108891\ \(0\)\
\-\ related\\:\\ 0\\.013015687798051524\ \(0\)\
\-\ limits\\:\\ 0\\.012997098152184524\ \(0\)\
\-\ \\,\\:\\ 0\\.012986091703781314\ \(0\)\
\-\ are\\:\\ 0\\.012895282721729908\ \(0\)\
\-\ treatment\\:\\ 0\\.012764700808862635\ \(0\)\
\-\ currently\\:\\ 0\\.012495102564620136\ \(0\)\
\-\ seen\\:\\ 0\\.012462196421163765\ \(0\)\
\-\ film\\:\\ 0\\.012111176882800657\ \(0\)\
\-\ commonly\\:\\ 0\\.011898640012751444\ \(0\)\
\-\ abnormality\\:\\ 0\\.011633055143286171\ \(0\)\
\-\ abnormalities\\:\\ 0\\.011582157275639176\ \(0\)\
\-\ venous\\:\\ 0\\.011445703389140697\ \(0\)\
\-\ identified\\:\\ 0\\.011267406056038086\ \(0\)\
\-\ signs\\:\\ 0\\.011097328169690238\ \(0\)\
\-\ for\\:\\ 0\\.01076174389140539\ \(0\)\
\-\ elevated\\:\\ 0\\.010698584359258535\ \(0\)\
\-\ areas\\:\\ 0\\.010610137163269619\ \(0\)\
\-\ cases\\:\\ 0\\.010504837136461742\ \(0\)\
\-\ unremarkable\\:\\ 0\\.010439359478531588\ \(0\)\
\-\ bilaterally\\:\\ 0\\.01035684589861219\ \(0\)\
\-\ vascular\\:\\ 0\\.010338757446212902\ \(0\)\
\-\ plain\\:\\ 0\\.010240825508077802\ \(0\)\
\-\ between\\:\\ 0\\.00999444847315219\ \(0\)\
\-\ normal\\:\\ 0\\.00988643877932916\ \(0\)\
\-\ clinical\\:\\ 0\\.009702250184745402\ \(0\)\
\-\ her\\:\\ 0\\.009481223832047733\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.00942445291382087\ \(0\)\
\-\ there\\:\\ 0\\.009385354660258218\ \(0\)\
\-\ pulmonary\\:\\ 0\\.009212362768339716\ \(0\)\
\-\ infection\\:\\ 0\\.009166112819456852\ \(0\)\
\-\ loss\\:\\ 0\\.009153004326451806\ \(0\)\
\-\ s\\:\\ 0\\.009043423125884084\ \(0\)\
\-\ following\\:\\ 0\\.008949364416609403\ \(0\)\
\-\ y\\/o\\:\\ 0\\.00873294844951897\ \(0\)\
\-\ \\:\\:\\ 0\\.00834151155712668\ \(0\)\
\-\ is\\:\\ 0\\.00829949488390739\ \(0\)\
\-\ physical\\:\\ 0\\.0077361818065728345\ \(0\)\
\-\ increased\\:\\ 0\\.0077139659845005745\ \(0\)\
\-\ \\%\\:\\ 0\\.007355428167328441\ \(0\)\
\-\ woman\\:\\ 0\\.007283774713981204\ \(0\)\
\-\ most\\:\\ 0\\.007279834471321313\ \(0\)\
\-\ can\\:\\ 0\\.007152112001730884\ \(0\)\
\-\ this\\:\\ 0\\.007093263566893971\ \(0\)\
\-\ exam\\:\\ 0\\.006927062509038886\ \(0\)\
\-\ case\\:\\ 0\\.006898540342683656\ \(0\)\
\-\ had\\:\\ 0\\.00680387387173693\ \(0\)\
\-\ \\-\\:\\ 0\\.0067591456040899025\ \(0\)\
\-\ no\\:\\ 0\\.006350141333607394\ \(0\)\
\-\ also\\:\\ 0\\.006216308463727496\ \(0\)\
\-\ within\\:\\ 0\\.006015245049395135\ \(0\)\
\-\ which\\:\\ 0\\.005886142388348888\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.005782340780796634\ \(0\)\
\-\ that\\:\\ 0\\.005446423352615584\ \(0\)\
\-\ disease\\:\\ 0\\.00515401306721662\ \(0\)\
\-\ be\\:\\ 0\\.004862570934848447\ \(0\)\
\-\ as\\:\\ 0\\.004769658693336265\ \(0\)\
\-\ to\\:\\ 0\\.0047276912373762315\ \(0\)\
\-\ history\\:\\ 0\\.004355035194491082\ \(0\)\
\-\ and\\:\\ 0\\.003985439241303729\ \(0\)\
\-\ or\\:\\ 0\\.003695655900235083\ \(0\)\
\-\ was\\:\\ 0\\.003646780524773752\ \(0\)\
\-\ the\\:\\ 0\\.0035710147340419947\ \(0\)\
\-\ patient\\:\\ 0\\.003160855833639808\ \(0\)\
\-\ in\\:\\ 0\\.0031099426578616598\ \(0\)\
\-\ a\\:\\ 0\\.002926935806779345\ \(0\)\
\-\ \\.\\:\\ 0\\.0028818811591941624\ \(0\)\
\-\ on\\:\\ 0\\.0026711845474739044\ \(0\)\
\-\ \\(\\:\\ 0\\.002665541425254098\ \(0\)\
\-\ \\)\\:\\ 0\\.0026329804137022327\ \(0\)\
\-\ of\\:\\ 0\\.0017196132959112682\ \(0\)\
\-\ with\\:\\ 0\\.0008634994545379316\ \(0\)\
